Article
RAC1 and melanoma.
Clinical therapeutics - 1 Mar 2015
Halaban Ruth
Abstract excerpt
RAC1 is a GTPase member of the RAS superfamily, and RAC1(P29S) was recently identified as the third most common recurrent mutation in melanomas, affecting 4-7% of the patients. This is an oncogenic mutation, because the mutant protein remains mostly in its active GTP-bound form, and its ectopic expression increases the rate of normal melanocytes proliferation and migration. There is limited information regarding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
